OptimumBank Holdings, Inc. (OPHC) - Dilution Analysis

10-Q filing | 12.0M shares outstanding

8-K filing: OptimumBank Holdings, Inc. and Michael Blisko completed an Exchange Agreement where Mr. Blisko exchanged 65 shares of Company Series B Convertible Preferred Stock for 531,178 newly issued shares of Company common stock.

10-Q filing | 11.8M shares outstanding

10-Q filing | 11.7M shares outstanding

10-K filing | 11.8M shares outstanding

10-Q filing | 10.3M shares outstanding

S-3 filing: OPTIMUMBANK HOLDINGS, INC. has entered into an At Market Issuance Sales Agreement with Compass Point Research & Trading, LLC to offer and sell shares of its common stock up to an aggregate of $25.00 million from time to time through or to the Agent.

10-Q filing | 9.6M shares outstanding

S-3/A filing: The company filed an S-3/A registration statement relating to shares of common stock sold in a private placement that closed on March 28, 2024. The company agreed to file a registration statement covering all shares of common stock sold in the Private Placement within 30 days of closing.

S-3/A filing: The company filed an S-3/A to register shares of common stock sold in a private placement that closed on March 28, 2024. The purchase price was $3.90 per share.

10-Q filing | 9.6M shares outstanding

S-3 filing: The company is filing a registration statement for shares of common stock sold in a private placement that closed on March 28, 2024, at a price of $3.90 per share. Compass Point Research and Trading, LLC acted as the placement agent.

8-K filing: OptimumBank Holdings, Inc. issued and sold 1,511,025 shares of common stock and 525,641 shares of Series C preferred stock at $3.90 per share, for $7,942,997 in gross proceeds. ($7.94M proceeds)

10-K filing | 7.2M shares outstanding

10-Q filing | 7.3M shares outstanding

10-Q filing | 7.3M shares outstanding

10-Q filing | 7.2M shares outstanding

10-K filing | 7.3M shares outstanding

10-Q filing | 6.8M shares outstanding

8-K filing: On August 23, 2022, the Company sold 17,000 shares of the Company's common stock to Mr. Newman for a cash price of $4.50 per share, totaling $76,500. ($0.08M proceeds)

10-Q filing | 6.0M shares outstanding

10-Q filing | 6.0M shares outstanding

10-K filing | 4.9M shares outstanding

10-Q filing | 4.7M shares outstanding

10-Q filing | 4.4M shares outstanding

8-K filing: The company issued 467,740 shares of its common stock in a private placement transaction to seven accredited investors at a price of $4.50 per share, for aggregate proceeds of $2,104,830. ($2.1M proceeds)

8-K filing: The Company completed a private offer to exchange its Trust Preferred Securities for 689,572 shares of common stock at a price of $3.00 per share, issuing shares to five accredited investors including entities controlled by two of the Company's directors. ($2.07M proceeds)

8-K filing: OptimumBank closed a private placement with Aaron Mauer on June 25, 2021, where Mr. Mauer purchased 200 shares of the company's Series B Preferred Stock for $5,000,000. ($5.0M proceeds)

10-Q filing | 3.2M shares outstanding

10-K filing | 3.2M shares outstanding

10-Q filing | 3.0M shares outstanding

8-K filing: The company entered into a Purchase Agreement with Michael Blisko to sell 180 shares of Series B Preferred Stock for $4,500,000, which was completed on September 29, 2020. The company also filed an amendment to its Certificate of Designation for the Series B Preferred Stock, increasing the authorized shares from 100 to 280. ($4.5M proceeds)

10-Q filing | 3.0M shares outstanding

8-K filing: The company entered into a purchase agreement with Michael Blisko for the sale of 100 shares of Series B Preferred Stock at a price of $2,500,000, which closed on June 23, 2020. ($2.5M proceeds)

10-Q filing | 3.0M shares outstanding

10-K filing | 1.9M shares outstanding

8-K filing: The Company issued 924,395 shares of its common stock in exchange for 1,881 Trust Preferred Securities at a price of $2.86 per share. ($2.64M proceeds)